Internal Medicine, Hematology & Oncology · Canfield, OH
NPI
1023376449
Since 2012
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
1
Medicare group memberships
Hospitals
4
Hospital affiliations
3695a Boardman Canfield Rd
Canfield, OH, 44406
Phone (330) 533-3040
Groups this clinician bills Medicare through
Medicare paid, 2024
$2.7M
196,378 services
Medicare patients, 2024
531
Average age 74
Drug cost, 2024
$16.9M
3,727 prescriptions
Company payments, 2025
$3,769
From 56 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by John J Graham was code J0881 (injection, darbepoetin alfa, 1 microgram (non-esrd use)), 28,000 times for 16 patients. In total John J Graham billed 196,378 services in 123 codes, and Medicare paid $2.7M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2024-04-30.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J0881 Injection, darbepoetin alfa, 1 microgram (non-esrd use) | Office | 28,000 | 16 | $1.45 | $41K |
| J1439 Injection, ferric carboxymaltose, 1 mg | Office | 21,000 | 14 | $0.82 | $17K |
| J0897 Injection, denosumab, 1 mg | Office | 10,860 | 18 | $12.93 | $140K |
| J1453 Injection, fosaprepitant, 1 mg | Office | 6,900 | 12 | $0.11 | $786 |
| J1449 Injection, eflapegrastim-xnst, 0.1 mg | Office | 4,224 | 13 | $18.03 | $76K |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 2,076 | 37 | $0.09 | $188 |
| 36415 Venipuncture Blood Collection | Office | 1,355 | 299 | $8.59 | $12K |
| 85025 Blood Count | Office | 1,313 | 298 | $7.54 | $9,904 |
| 80053 Clinical Chemistry | Office | 1,210 | 296 | $10.26 | $12K |
| J2469 Injection, palonosetron hcl, 25 mcg | Office | 1,040 | 23 | $0.75 | $780 |
| 96375 Injection Administration | Office | 704 | 53 | $11.51 | $8,101 |
| 99213 Office E&M - Established | Office | 524 | 213 | $60.39 | $32K |
| 96413 Chemotherapy Administration | Office | 358 | 45 | $93.66 | $34K |
| 99214 Office E&M - Established | Office | 335 | 80 | $92.74 | $31K |
| 96372 Injection Administration | Office | 307 | 51 | $10.64 | $3,265 |
By year: 2022 $2.3M for 191,988 services; 2023 $1.7M for 142,295 services; 2024 $2.7M for 196,378 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 1,355 | 299 | $8.59 | $12K |
| 85025 Blood Count | 1,313 | 298 | $7.54 | $9,904 |
| 80053 Clinical Chemistry | 1,210 | 296 | $10.26 | $12K |
| 82784 Immunoassay | 291 | 33 | $9.11 | $2,652 |
| 83540 Clinical Chemistry | 262 | 76 | $6.32 | $1,655 |
| 82728 Clinical Chemistry | 262 | 77 | $13.31 | $3,488 |
| 84466 Clinical Chemistry | 262 | 76 | $12.46 | $3,264 |
| 84443 Clinical Chemistry | 135 | 30 | $16.46 | $2,222 |
| 86300 Immunoassay | 134 | 47 | $20.13 | $2,698 |
| 83883 Clinical Chemistry | 99 | 19 | $13.33 | $1,320 |
Medicare prescription drug claims, 2024
In 2024, the drug John J Graham prescribed most often to Medicare patients was Neulasta Onpro (Pegfilgrastim), with 155 prescriptions and refills. In total John J Graham wrote 3,727 Medicare prescriptions that cost $16.9M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Neulasta Onpro Pegfilgrastim | 155 | 155 | 34 | $970K |
| Octagam Immun Globg(Igg)/Malt/Iga Ov50 | 145 | 145 | Under 11 | $983K |
| Hydroxyurea Generic | 135 | 192 | 24 | $2,251 |
| Ondansetron Odt Ondansetron | 117 | 118 | 78 | $2,245 |
| Acyclovir Generic | 117 | 132 | 20 | $1,297 |
| Imbruvica Ibrutinib | 116 | 116 | Under 11 | $1.8M |
| Bortezomib Generic | 113 | 113 | Under 11 | $27K |
| Letrozole Generic | 112 | 218 | 24 | $2,640 |
| Aranesp Darbepoetin Alfa In Polysorbat | 111 | 111 | 18 | $159K |
| Prochlorperazine Maleate Generic | 102 | 102 | 74 | $2,597 |
| Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen | 91 | 91 | 29 | $3,371 |
| Anastrozole Generic | 88 | 154 | 18 | $1,699 |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 76 | 107 | 21 | $680 |
| Revlimid Lenalidomide | 70 | 70 | 12 | $1.3M |
| Brukinsa Zanubrutinib | 68 | 68 | Under 11 | $999K |
Brand drugs: 1,884 claims; generic drugs: - claims; opioid claims: 211.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid John J Graham $3,769 ($3,769 in general payments such as food, travel and fees) from 56 companies. The largest payer was Daiichi Sankyo Inc. with $273.
| Company | Payments | Amount |
|---|---|---|
| Daiichi Sankyo Inc. 4568.T | 16 | $273 |
| Novartis Pharmaceuticals Corporation NVS | 11 | $251 |
| AstraZeneca Pharmaceuticals LP AZN | 7 | $248 |
| E.R. Squibb & Sons, L.L.C. BMY | 16 | $205 |
| Abbvie Inc. ABBV | 12 | $201 |
| Exelixis Inc. EXEL | 4 | $195 |
| Geron Corporation GERN | 3 | $161 |
| Lilly USA, LLC LLY | 2 | $153 |
| Genzyme Corporation SNY | 6 | $152 |
| Syndax Pharmaceuticals, Inc. SNDX | 2 | $142 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.